In this article, we will discuss Golimumab (Indications). So, let’s get started.
Golimumab is a tumor necrosis factor (TN) blocker indicated for the treatment
(1) Moderately to severely active Rheumatoid Arthritis (RA) in adults, in combination with methotrexate.
(2) Active Psoriatic Aithritis (PsA) in adults, alone or in combination with methotrexate.
(3) Active Ankylosing Spondylitis in adults (AS).